Janiczek Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$310K Buy
1,805
+40
+2% +$6.63K 0.06% 126
2024
Q1
$321K Sell
1,765
-466
-21% -$80.3K 0.07% 124
2023
Q4
$346K Buy
2,231
+247
+12% +$36K 0.08% 97
2023
Q3
$296K Buy
1,984
+789
+66% +$116K 0.08% 101
2023
Q2
$161K Sell
1,195
-174
-13% -$25.5K 0.04% 158
2023
Q1
$222K Sell
1,369
-43
-3% -$6.57K 0.06% 112
2022
Q4
$216K Sell
1,412
-137
-9% -$21K 0.06% 113
2022
Q3
$214K Buy
1,549
+455
+42% +$65.3K 0.07% 94
2022
Q2
$157K Buy
1,094
+28
+3% +$4.28K 0.05% 137
2022
Q1
$173K Buy
1,066
+174
+20% +$25.3K 0.05% 132
2021
Q4
$121K Buy
892
+266
+42% +$31.4K 0.04% 166
2021
Q3
$68K Sell
626
-127
-17% -$14.5K 0.02% 232
2021
Q2
$85K Buy
753
+29
+4% +$3.27K 0.03% 174
2021
Q1
$78K Buy
724
+356
+97% +$38.1K 0.03% 174
2020
Q4
$39K Buy
368
+266
+261% +$25.6K 0.02% 239
2020
Q3
$9K Buy
+102
New +$9.6K ﹤0.01% 248
2018
Q3
Sell
-12
Closed -$1K 147
2018
Q2
$1K Buy
+12
New +$1.17K ﹤0.01% 136

Other funds holding ABBV

Janiczek Wealth Management's ABBV Position: Q2 2024 in Review

Janiczek Wealth Management increased its AbbVie (ABBV) stake by 2.3% in Q2 2024, buying an estimated $6.63K and bringing the position to 1,805 shares worth $310K. The position accounts for 0.06% of the portfolio, ranked #126.

Janiczek Wealth Management first reported a position in ABBV in Q2 2018 and has held it in 17 quarters since. The position peaked at $346K in Q4 2023. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Janiczek Wealth Management held 1,805 shares of AbbVie worth $310K as of Q2 2024.
  • Janiczek Wealth Management bought 40 AbbVie shares in Q2 2024, an estimated $6.63K.
  • AbbVie made up 0.06% of Janiczek Wealth Management's portfolio in Q2 2024, its #126 holding.
  • Janiczek Wealth Management first reported a position in AbbVie in Q2 2018 and has held it in 17 quarters since.
  • Janiczek Wealth Management's AbbVie position peaked at $346K in Q4 2023.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.